WallStreetZenWallStreetZen

NYSE: CRL
Charles River Laboratories International Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Charles River Laboratories International earnings were -$31.6M for the trailing 12 months ending Mar 29, 2025, with N/A growth year over year. The latest CRL earnings report on Mar 29, 2025 announced Q1 2025 earnings of $25.5M, down 111.8% from last quarter. For the last reported fiscal year 2024 ending Dec 28, 2024, CRL reported annual earnings of $10.3M, with -97.8% growth. The next CRL earnings date is Jul 30, 2025.

CRL earnings history

Current Revenue
$4.0B
Current Earnings
-$31.6M
Current Profit Margin
-0.8%

CRL Return on Equity

Current Company
-0.9%
Current Industry
-10.3%
Current Market
31.3%
CRL's Return on Equity (-0.9%)... subscribe to Premium to read more.
High Return on Equity Performance

CRL undefined

Current Company
-0.4%
Current Industry
6%
CRL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRL announces earnings.

CRL undefined

Current Company
2.25%
Current Industry
10.8%
CRL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRL vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRL$544.03M-$31.56MN/A-$0.60
GH-$370.74M-$416.55MN/A-$3.39
MEDP$513.12M$416.39M+34.67%$13.51
EXAS-$758.08M-$1.02BN/A-$5.54
QGEN$372.10M$93.68M-32.17%$0.43
View Top Diagnostic & Research Stocks

CRL earnings dates

Next earnings date
Jul 30, 2025

Charles River Laboratories International Earnings Reports & History FAQ

What were Charles River Laboratories International's earnings last quarter?

On CRL's earnings call on Invalid Date, Charles River Laboratories International (NYSE: CRL) reported Q1 2025 earnings per share (EPS) of $0.50, up 61.83% year over year. Total CRL earnings for the quarter were $25.47 million. In the same quarter last year, Charles River Laboratories International's earnings per share (EPS) was $1.31.

If you're new to stock investing, here's how to buy Charles River Laboratories International stock.

When does Charles River Laboratories International report earnings?

The next CRL earnings call is Invalid Date. Add CRL to your watchlist to be reminded of Charles River Laboratories International's next earnings date.

Is Charles River Laboratories International profitable or losing money?

As of the last Charles River Laboratories International earnings report, Charles River Laboratories International is currently losing money. Charles River Laboratories International's net profit (also called net income) for the twelve months ending Mar 29, 2025 was -$25.29 million, a 105.69% decrease year over year.

What was CRL's earnings growth in the past year?

As of Charles River Laboratories International's earnings date in Invalid Date, Charles River Laboratories International's earnings has grown year over year. CRL earnings in the past year totalled -$31.56 million.

What are Charles River Laboratories International's earnings expectations?

The current EPS estimate for Charles River Laboratories International's earnings report in Invalid Date is $2.50.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.